Pathophysiology of worsening lung function in COVID-19

Autores

  • Giulliano Gardenghi ENCORE

DOI:

https://doi.org/10.33233/rbfe.v19i2.4058

Resumo

Introduction: The new coronavirus pneumonia (COVID-19) has emerged as the main threats to global health since December 2019. Addressing part of the pulmonary pathophysiology involved in the disease is important to help interested health professionals better understand the different aspects of this complex pathology. Aim: This article aims to present part of the pathophysiological process involved in pulmonary complications associated with Covid-19. Methods: An integrative literature review was carried out, with articles published between 2019 and 2020, in the Google and PubMed databases, using the following search terms: coronavirus, COVID-19, pulmonary complications, pneumonia. Results: 6 articles were included, addressing the proposed theme. Conclusion: The individual's infection with COVID-19 has the potential to cause significant changes in ventilatory capacity, leading to diffuse pulmonary impairment and worsening gas exchange. Further studies are needed to clarify the pathophysiology of this complex disease with a high potential for contagion, morbidity and mortality.

Keywords: coronavirus infections, communicable diseases, pneumonia.

  

Biografia do Autor

Giulliano Gardenghi, ENCORE

PhD, Scientific Coordinator of Hospital ENCORE, Aparecida de Goiânia/GO, Scientific Coordinator of the CEAFI Faculty, Goiânia/GO, Technical Consultant of Lifecare / HUGOL – Burns Intensive Care Unit, Goiânia/GO, Technical Consultant at São Cristóvão Hospital and Maternity, São Paulo/SP

Referências

- World Health Organization - WHO. Coronavirus disease (COVID-19) Pandemic [accessed in Apr 10 2020]; Available in: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S0140-6736(20)30211-7

- Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L. Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID-19). Preprints 2020, 2020020407 [periódicos na Internet]. [acesso em 10 abr 2020]; Disponível em: https://www.preprints.org/manuscript/202002.0407/v1

- Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20(4):425-34. https://doi.org/10.1016/S1473-3099(20)30086-4

- Wenzhong L, Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv 2020; Preprint. https://doi.org/10.26434/chemrxiv.11938173.v6

Downloads

Publicado

2020-04-23

Edição

v. 19 n. 2 (2020): Suplemento COVID-19

Seção

Reviews

Licença

Autores que publicam nesta revista concordam com os seguintes termos:  Autores mantém os direitos autorais e concedem à  revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a  Licença Creative Commons Attribution  que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista; Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capí­tulo de livro), com reconhecimento de autoria e publicação inicial nesta revista; Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja  O Efeito do Acesso Livre).